Exact Mass: 433.1799
Exact Mass Matches: 433.1799
Found 220 metabolites which its exact mass value is equals to given mass value 433.1799
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Meleagrine
An indole alkaloid with a heterotetracyclic skeleton isolated from Penicillium oxalicum.
Brexpiprazole
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].
Fenfangjine G
(1R)-(4-hydroxybenzyl)-7-hydroxyl-8-O-beta-D-glucopyranosyl-1,2,3,4-tetrahydroisoquinoline
(-)-8alpha-(4-methoxybenzyl)-2-methoxyberbin-3,10,11-triol|(-)-8alpha-<4-methoxybenzyl>-2-methoxyberbin-3,10,11-triol|O4-Me-8-(4-Hydroxybenzyl)-2-methoxy-3,10,11-berbintriol
C23H23N5O4_(3Z)-6-Hydroxy-3-(1H-imidazol-5-ylmethylene)-12-methoxy-7a-(2-methyl-3-buten-2-yl)-7a,12-dihydro-1H,5H-imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione
Ala Asp Gln Thr
Ala Asp Thr Gln
Ala Glu Asn Thr
Ala Glu Gln Ser
Ala Glu Ser Gln
Ala Glu Thr Asn
Ala Asn Glu Thr
Ala Asn Thr Glu
Ala Gln Asp Thr
Ala Gln Glu Ser
Ala Gln Ser Glu
Ala Gln Thr Asp
Ala Ser Glu Gln
Ala Ser Gln Glu
Ala Thr Asp Gln
Ala Thr Glu Asn
Ala Thr Asn Glu
Ala Thr Gln Asp
Asp Ala Gln Thr
Asp Ala Thr Gln
Asp Asp Gly Lys
Asp Asp Lys Gly
Asp Gly Asp Lys
Asp Gly Lys Asp
Asp Lys Asp Gly
Asp Lys Gly Asp
Asp Asn Ser Val
Asp Asn Val Ser
Asp Gln Ala Thr
Asp Gln Thr Ala
Asp Ser Asn Val
Asp Ser Val Asn
Asp Thr Ala Gln
Asp Thr Gln Ala
Asp Val Asn Ser
Asp Val Ser Asn
Glu Ala Asn Thr
Glu Ala Gln Ser
Glu Ala Ser Gln
Glu Ala Thr Asn
Glu Gly Gln Thr
Glu Gly Thr Gln
Glu Asn Ala Thr
Glu Asn Thr Ala
Glu Gln Ala Ser
Glu Gln Gly Thr
Glu Gln Ser Ala
Glu Gln Thr Gly
Glu Ser Ala Gln
Glu Ser Gln Ala
Glu Thr Ala Asn
Glu Thr Gly Gln
Glu Thr Asn Ala
Glu Thr Gln Gly
Gly Asp Asp Lys
Gly Asp Lys Asp
Gly Glu Gln Thr
Gly Glu Thr Gln
Gly Lys Asp Asp
Gly Gln Glu Thr
Gly Gln Thr Glu
Gly Thr Glu Gln
Gly Thr Gln Glu
Lys Asp Asp Gly
Lys Asp Gly Asp
Lys Gly Asp Asp
Asn Ala Glu Thr
Asn Ala Thr Glu
Asn Asp Ser Val
Asn Asp Val Ser
Asn Glu Ala Thr
Asn Glu Thr Ala
Asn Ser Asp Val
Asn Ser Val Asp
Asn Thr Ala Glu
Asn Thr Glu Ala
Asn Val Asp Ser
Asn Val Ser Asp
Gln Ala Asp Thr
Gln Ala Glu Ser
Gln Ala Ser Glu
Gln Ala Thr Asp
Gln Asp Ala Thr
Gln Asp Thr Ala
Gln Glu Ala Ser
Gln Glu Gly Thr
Gln Glu Ser Ala
Gln Glu Thr Gly
Gln Gly Glu Thr
Gln Gly Thr Glu
Gln Ser Ala Glu
Gln Ser Glu Ala
Gln Thr Ala Asp
Gln Thr Asp Ala
Gln Thr Glu Gly
Gln Thr Gly Glu
Ser Ala Glu Gln
Ser Ala Gln Glu
Ser Asp Asn Val
Ser Asp Val Asn
Ser Glu Ala Gln
Ser Glu Gln Ala
Ser Asn Asp Val
Ser Asn Val Asp
Ser Gln Ala Glu
Ser Gln Glu Ala
Ser Val Asp Asn
Ser Val Asn Asp
Thr Ala Asp Gln
Thr Ala Glu Asn
Thr Ala Asn Glu
Thr Ala Gln Asp
Thr Asp Ala Gln
Thr Asp Gln Ala
Thr Glu Ala Asn
Thr Glu Gly Gln
Thr Glu Asn Ala
Thr Glu Gln Gly
Thr Gly Glu Gln
Thr Gly Gln Glu
Thr Asn Ala Glu
Thr Asn Glu Ala
Thr Gln Ala Asp
Thr Gln Asp Ala
Thr Gln Glu Gly
Thr Gln Gly Glu
Val Asp Asn Ser
Val Asp Ser Asn
Val Asn Asp Ser
Val Asn Ser Asp
Val Ser Asp Asn
Val Ser Asn Asp
6-(methylamino)hexane-1,2,3,4,5-pentol,4-(2H-tetrazol-5-yl)tetrazolo[1,5-a]quinoline
3-[[4-(diethylamino)phenyl]azo]-1,2-dimethyl-1H-indazolium methyl sulphate
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-fluorophenyl)-N-(3-pyridinylmethyl)- (9CI)
N-(2,4-dimethoxyphenyl)-2-[1-(3,4-dimethylphenyl)-4-oxo-5-pyrazolo[3,4-d]pyrimidinyl]acetamide
5-[(3,4-Dimethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-2-methyl-6-thiazolo[3,2-b][1,2,4]triazolol
Brexpiprazole
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].
(3Z)-3-[(2E,4E,6R)-1-hydroxy-6-[(2S,7R,8R)-2-(hydroxymethyl)-1,7-dimethyl-5-oxo-3,9,10-trioxatricyclo[4.3.1.02,4]decan-8-yl]-4-methylhepta-2,4-dienylidene]pyrrolidine-2,4-dione
(3E,7aS,12aR)-6-hydroxy-3-(1H-imidazol-4-ylmethylidene)-12-methoxy-7a-(2-methylbut-3-en-2-yl)-7a,12-dihydro-1H,5H-imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione
3-(3,4,5-Trimethoxyphenyl)propanoic acid [2-(3,5-dimethoxyanilino)-2-oxoethyl] ester
(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-N-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
Izilendustat
Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1].